“Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland”, Swiss Med Wkly, vol. 156, no. 6, p. 5062, Jun. 2026, doi: 10.57187/5062.